Nottingham, United Kingdom

Tina Parsons



 

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2007-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Tina Parsons: Innovator in Cancer Research

Introduction

Tina Parsons is a prominent inventor based in Nottingham, GB. She has made significant contributions to the field of cancer research, holding a total of 8 patents. Her work focuses on innovative treatments and pharmaceutical compositions aimed at targeting cancer effectively.

Latest Patents

Among her latest patents is "Sialyl-di-Lewisas expressed on glycoproteins but not glycolipids as a functional cancer target and antibodies thereto." This invention relates to an isolated specific binding member capable of binding sialyl-di-Lewis, along with associated treatments and pharmaceutical compositions for cancer treatment. Another notable patent is "Glycans as functional cancer targets and antibodies thereto," which describes a glycan structure attached to a lipid or protein backbone, along with isolated binding members capable of binding to it.

Career Highlights

Tina has worked with notable companies in the industry, including Cephalon Australia Pty. Ltd. and Scancell Limited. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative cancer therapies.

Collaborations

Tina has collaborated with several professionals in her field, including Linda Gillian Durrant and Lindy Gillian Durrant. These collaborations have enriched her research and expanded her impact on cancer treatment.

Conclusion

Tina Parsons is a dedicated inventor whose work in cancer research has led to significant advancements in treatment options. Her innovative patents and collaborations highlight her commitment to improving healthcare outcomes for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…